Legislation would radically ease research restrictions on cannabis and other schedule I substances
A recently introduced bill, if it passes, would allow research on cannabis despite its schedule I status, which some experts say could help policymakers “craft effective” legislation in the future and potentially allow more clinical research on medical cannabis.
Representatives Dina Titus and Ilhan Omar introduced the Evidence-Based Drug Policy Act of 2025 (EBDPA) last week, which would radically ease research restrictions on cannabis and other schedule I substances.
Legislation would radically ease research restrictions on cannabis and other schedule I substancesA recently introduced bill, if it passes, would allow research on cannabis despite its schedule I status, which some experts say could help policymakers “craft effective” legislation in the future and potentially allow more clinical research on medical cannabis.Representatives Dina Titus and Ilhan Omar introduced the Evidence-Based Drug Policy Act of 2025 (EBDPA) last week, which would radically ease research restrictions on cannabis and other schedule I substances. Continue reading… US news | The Guardian